Extendicare buys back shares

Article Excerpt

EXTENDICARE INC., $7.33, is a buy. The company (Toronto symbol EXE; TSINetwork Rating: Extra Risk) (www.extendicare.com; Shares o/s: 83.5 million; Market cap: $611.8 million; Dividend yield: 6.6%) keeps buying back shares. Under TSX approval, for the period June 30, 2023, to June 29, 2024, it repurchased 1.1 million of its shares at an average price of $6.23. Over the next year, it plans to keep buying back more of its stock. Stock buybacks reduce the total number of shares outstanding. That boosts earnings per share since profit is divided among fewer shares. The higher per-share earnings make the stock more attractive to investors and helps to increase share prices. Extendicare is still a buy. buy…